Outset Medical Inc reports results for the quarter ended March 31 - Earnings Summary

Outset Medical

07/05/2025 22:06

Outset Medical Inc OM.OQ reported a quarterly adjusted loss of $3.24​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-8.55.  The mean expectation of five analysts for the quarter was for a loss of 94 cents per share. Wall Street expected results to range from $-1.45 to -31 cents per share.

Revenue rose 5.6% to $29.75 million from a year ago; analysts expected $27.81 million.

Outset Medical Inc's reported EPS for the quarter was a loss of $3.66​.

The company reported a quarterly loss of $25.78 million.

Outset Medical Inc shares had risen by 4.3% this quarter and lost 30.7% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 77.5% in the last three months.​

In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Outset Medical Inc is $15.00

This summary was machine generated from LSEG data May 7 at 09:06 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.94
-3.24
Missed
Dec. 31 2024
-6.19
-5.55
Beat
Sep. 30 2024
-6.33
-5.85
Beat
Jun. 30 2024
-6.78
-7.05
Missed